-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
Blunting specific T-dependent antibody responses with engineered “decoy” B cells
Veröffentlicht in Molecular therapy
VolltextArtikel -
19
-
20